Larvol Delta - Bright-Peak-Therapeutics-Announces-90-Million-in-Series-C-Financing-to-Advance-FirstinClass-PD1IL18-Immunoconjugate-Program-Into-Clinical-Trials

BPT567 - Bright Peak Therap

https://www.globenewswire.com/news-release/2024/06/11/2896527/0/en/Bright-Peak-Therapeutics-Announces-90-Million-in-Series-C-Financing-to-Advance-First-in-Class-PD1-IL18-Immunoconjugate-Program-Into-Clinical-Trials.html

Jun 11, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next